Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +60.7% | -13.6% | 1 / 3 | -20.7% | +1.67 pp | +0.87 pp | +1.9% | 0.72 | 21.68 | 784 | −20,7% | 13,2 | +63,2% | 21.68 | 21.16 | +2,5% |
| Pts | 12 | 0 | 4 | 0 | 8 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 4.600 (close price on 2026-10-19)EPS (TTM): 212,1
Financial charts
1.Revenue & growth
VND bn784Q2/26
1.Revenue & growth
VND bn784Q2/26
2.Profit & growth
VND bn13,2Q2/26
3.Profit mix (Penman)
VND bn112Q2/26
4.Margins & cost structure
%13.6%Q2/26
5.Returns & cash cycle
% · days2.8%Q2/26
6.Earnings quality & cash
VND bn26,8Q2/26
7.Asset structure
VND bn9.173Q2/26
8.Funding & debt health
VND bn · times9.173Q2/26
9.Revenue backlog
VND bn777Q2/26
10.Valuation
times · %21,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %37Q2/26
Adjusted EPS growth, latest quarter
60.7%
Average adjusted EPS growth, 3 quarters
-13.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26